This inventor holds 1 USPTO granted patent. Top assignee: Progenica Therapeutics, LLC. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Helen Newman: Innovator in Bone Graft Technology
Introduction
Helen Newman is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of biomedical engineering, particularly in the development of advanced bone graft materials. Her innovative work focuses on enhancing the effectiveness of bone grafts through novel compositions.
Latest Patents
Helen Newman holds a patent for a surface enhanced demineralized bone graft material. This patent describes compositions that comprise a BMP-2 derived peptide conjugated to albumin for use in bone grafts. The composition may further include bone matrix, such as demineralized bone matrix (DBM). This invention represents a significant advancement in the field of regenerative medicine.
Career Highlights
Helen is currently associated with Progenica Therapeutics, LLC, where she continues to push the boundaries of innovation in bone graft technology. Her work is instrumental in developing solutions that improve patient outcomes in orthopedic and dental procedures.
Collaborations
Helen collaborates with notable professionals in her field, including Abdulhafez Abdulwahed and Lawrence A. Shimp. These collaborations enhance the research and development efforts at Progenica Therapeutics, LLC.
Conclusion
Helen Newman is a trailblazer in the field of bone graft technology, with her innovative patent contributing to advancements in regenerative medicine. Her work exemplifies the impact of dedicated inventors in improving healthcare solutions.